My bookmarksSign up free

Commission Implementing Decision (EU) 2025/357 of 21 February 2025 not approving 5-chloro-2-methyl-2H-isothiazol-3-one (CIT) as an active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission Implementing Decision (EU) 2025/357 of 21 February 2025 not approving 5-chloro-2-methyl-2H-isothiazol-3-one (CIT) as an active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Implementing Decision (EU) 2025/357 · Decision · 2 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

5-chloro-2-methyl-2H-isothiazol-3-one (CIT) is not approved as an active substance for use in biocidal products of product-type 6.

Article 2

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next